Congenital Hypertrophy of the Retinal Pigment Epithelium (CHRPE) as a Screening Marker for Familial Adenomatous Polyposis (FAP): Systematic Literature Review and Screening Recommendations

References

• Baba S, Tsuchiya M, Watanabe I, Machida H. Importance of retinal pigmentation as a subclinical marker in familial adenomatous polyposis. Dis Colon Rectum. 1990;33(8):660–664.
   PubMed Web of Science ®Google Scholar
• Rehan S, Kyaw A. In patients with positive family history of familial adenomatous polyposis can the condition be diagnosed from the presence of congenital hypertrophy of the retinal pigment epithelium detected via an eye examination: a systematic review. Clin Exp Ophthalmol. 2020;48(1):98–116.
   PubMed Web of Science ®Google Scholar
• Leggett B, Poplawski B, Pachter N, Rosty C, Norton I, Rosty C. Cancer Council Australia Colorectal Cancer Guidelines. Colorectal Cancer/Familial Adenomatous Polyposis: Clinical Practice Guidelines for the Prevention, Early Detection and Management of Colorectal Cancer. [Internet]. Sydney: Cancer Council Australia; 2017. Available from: https://wiki.cancer.org.au/australia/Guidelines:Colorectal_cancer/Familial_adenomatous_polyposis#cite_note-Citation:Cancer_Institute_NSW_2016-1.AccessedAugust, 2021.
   Google Scholar
• Mirchils G, Tejpar S, Thoelen R, et al. Large deletions of the APC gene in 15 percent of mutation-negative patients with classical polyposis (FAP): a Belgian study. Hum Mutat. 2005;25(2):125.
   PubMed Web of Science ®Google Scholar
• National Health and Medical Research Council. NHMRC Levels of Evidence and Grades for Recommendation for Developers of Guidelines. Canberra: Australian Government, National Health and Medical Research Council; 2009.
   Google Scholar
• Mirinezshad S, Mousavi F, Baghri M, Sepehri B, Ghavidel A, Ghojazadeh M. Congenital hypertrophy of the retinal pigment epithelium for diagnosis of familial adenomatous polyposis – the first FAP registry in Iran. Asian Pac J Cancer Prev. 2018;19(1):167–169.
   PubMedGoogle Scholar
• Nusliha A, Dalpatadu U, Amarasinghe B, Chandrasinghe P, Deen K. Congenital hypertrophy of the retinal pigment epithelium (CHRPE) in patients with familial adenomatous polyposis (FAP): a polyposis registry experience. BMC Res Notes. 2014;7:734.
   PubMedGoogle Scholar
• Chen C, Phillips K, Grist S. Congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial colorectal cancer. Fam Cancer. 2006;5(4):397–404.
   PubMed Web of Science ®Google Scholar
• Tourino R, Conde-Freire R, Cabezas-Agricola J, et al. Value of the congenital hypertrophy of the retinal pigment epithelium in the diagnosis of familial adenomatous polyposis. Int Ophthalmol Clin. 2004;25(2):101–112.
   Google Scholar
• Rushwurm I, Zehetmayer M, Dejaco C, Wolf B, Karner-Hanusch J. Ophthalmic and genetic screening in pedigrees with familial adenomatous polyposis. Am J Ophthalmol. 1998;125(5):680–686.
   PubMed Web of Science ®Google Scholar
• Gelisken O, Yucel A, Guler K, Zorluoglu A. Ocular findings in familial adenomatous polyposis. Int Ophthalmol. 1998;21(4):205–208.
   Web of Science ®Google Scholar
• Lam D, Kwok S, Kwok A, Liew C, Lau J, Pang C. Incidence and predictive value of congenital hypertrophy of retinal pigment epithelium in Chinese familial adenomatous polyposis patients. Chin Med J (Engl). 1998;111(3):278–281.
   PubMed Web of Science ®Google Scholar
• Tiret A, Taiel-Sartral M, Tiret E, Laroche L. Diagnostic value of fundus examination in familial adenomatous polyposis. Br J Ophthalmol. 1997;81(9):755–758.
   PubMed Web of Science ®Google Scholar
• Traboulsi E, Apostolides J, Giardiello F, et al. Pigmented ocular fundus lesions and APC mutations in familial adenomatous polyposis. Ophthalmic Genet. 1996;17(4):167–174.
   PubMed Web of Science ®Google Scholar
• Rossato M, Rigotti M, Grazia M, Turco AE, Bonomi L. Congenital hypertrophy of the retinal pigment epithelium (CHRPE) and familial adenomatous polyposis (FAP). Acta Ophthalmol Scand. 1996;74(4):338–342.
   PubMedGoogle Scholar
• Olea J, Mateos J, Llompart A, Obrador A. Frequency of congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis. Acta Ophthalmol Scand. 1996;74(1):48–50.
   PubMedGoogle Scholar
• Valanzano R, Cama A, Volpe R, et al. Congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis; novel criteria of assessment and correlations with constitutional adenomatous polyposis coli gene mutations. Cancer. 1996;78(1):2400–2410.
   PubMed Web of Science ®Google Scholar
• Hunt L, Robinson M, Hugkulstone C, et al. Congenital hypertrophy of the retinal pigment epithelium and mandibular osteomata as markers in familial colorectal cancer. Br J Cancer. 1994;70(1):173–176.
   PubMed Web of Science ®Google Scholar
• Hodgson S, Bishop D, Jay B. Genetic heterogeneity of congenital hypertrophy of the retinal pigment epithelium (CHRPE) in families with familial adenomatous polyposis. J Med Genet. 1994;31(1):44–48.
   Web of Science ®Google Scholar
• Campbell W, Spence R, Parks T. The role of congenital hypertrophy of the retinal pigment epithelium in screening for familial adenomatous polyposis. Int J Colorect Dis. 1994;9:191–196.
   PubMed Web of Science ®Google Scholar
• Chagas C, Fidalgo P, Marins A, et al. Vale of congenital hypertrophy of the retinal pigment epithelium as diagnostic marker in familial adenomatous polyposis. Acta Med Port. 1993;6(7):303–306.
   PubMedGoogle Scholar
• Hickey-Dwyer M, Willoughby C. Assessment of the value of congenital hypertrophy of the retinal pigment epithelium as an ocular marker for familial adenomatous polyposis coli. Eye (Lond). 1993;7:562–564.
   PubMed Web of Science ®Google Scholar
• Bertario L, Russo A, Sala P, et al. Multiple approach to the exploration of genotype-phenotype correlations in familial adenomatous polyposis. J Clin Oncol. 2003;21(9):1698–16707.
   PubMed Web of Science ®Google Scholar
• Romania A, Zakov Z, Church J, Jagelman D. Retinal pigment epithelium lesions as a biomarker of disease in patients with familial adenomatous polyposis. A follow-up report. Ophthalmology. 1992;99(6):911–913.
   PubMed Web of Science ®Google Scholar
• Morton D, Gibson J, Macdonald F, et al. Role of congenital hypertrophy of the retinal pigment epithelium in the predictive diagnosis of familial adenomatous polyposis. Br J Surg. 1992;79(7):689–693.
   PubMed Web of Science ®Google Scholar
• Moore A, Maher E, Koch D, Charles S. Incidence and significance of congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial adenomatous polyposis coli (FAPC). Ophthalmic Paediatr Genet. 1992;13(6):67–71.
   PubMedGoogle Scholar
• Giardiello F, Offerhaus G, Traboulsi E, et al. Value of combined phenotypic markers in identifying inheritance of familial adenomatous polyposis. Gut. 1991;32(10):1170–1174.
   PubMed Web of Science ®Google Scholar
• Polkinghorne P, Ritchie S, Neale K, Schoeppner G, Thomson J, Jay B. Pigmented lesions of the retinal pigment epithelium and familial adenomatous polyposis. Eye (Lond). 1990;4:216–221.
   PubMed Web of Science ®Google Scholar
• Iwama T, Mishima Y, Okamoto N, Inoue J. Association of congenital hypertrophy of the retinal pigment epithelium with familial adenomatous polyposis. Br J Surg. 1990;77(3):273–276.
   PubMed Web of Science ®Google Scholar
• Heyen F, Jagelman D, Romania A, et al. Predictive value of congenital hypertrophy of the retinal pigment epithelium as a clinical marker for familial adenomatous polyposis. Colon Rectum. 1990;33:1003–1008.
   PubMed Web of Science ®Google Scholar
• Chapman P, Church W, Burn J, Gunn A. Congenital hypertrophy of retinal pigment epithelium: a sign of familial adenomatous polyposis. BMJ. 1989;298(6670):353–354.
   PubMed Web of Science ®Google Scholar
• Berk T, Cohen Z, Mcleod RS, Parker JA. Congenital hypertrophy of the retinal pigment epithelium as a marker for familial adenomatous polyposis. Dis Colon Rectum. 1988;31(4):253–257.
   PubMed Web of Science ®Google Scholar
• Hennessy M, Collins F, Coroneo M. The distinction between multiple retinal pigment epithelial hamartomata (MRPEH) in familial adenomatous polyposis (FAP) and congenital hypertrophy of the retinal pigment epithelium (CHRPE). Aust N Z J Ophthalmol. 1993;21(4):275–276.
   PubMedGoogle Scholar
• Shields J, Shields C. Tumors and Related Lesions of the Pigment Epithelium. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2008.
   Google Scholar
• Kiernan D, Ortiz-Morales G, Stuart K, Bhagat N, Lim J. Congenital Hypertrophy of the Retinal Pigment Epithelium. American Academy of Ophthalmology. Eyewiki; 2021. Available from: https://eyewiki.aao.org/Congenital_Hypertrophy_of_the_Retinal_Pigment_Epithelium. Accessed September, 2021.
   Google Scholar
• Chung DC, Rodgers LH Clinical manifestations and diagnosis of familial adenomatous polyposis; 2020. Available from: https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-familial-adenomatous-polyposis?Search=familial%20adenomatous%20polyposis&topicref=2485&source=see_link. Accessed Aug, 2021.
   Google Scholar
• Nielsen M, Infante E, Brand R MUTYH Polyposis. GeneReviews; 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK107219/. Accessed May, 2021.
   Google Scholar